AUROPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > auropharma

Technical Analysis

Technical Strength: 6 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 52.8. According to RSI analysis, auropharma just got above it's resistance level and showing good signal. 9.0 AUROPHARMA RSI Chart
MACD (?) MACD: -0.872 and Signal Line: 1.33. According to MACD analysis, auropharma is technically weak. 2.0 AUROPHARMA MACD Chart
Simple Moving Average (?) Price just got above it's 50-day simple moving average which is a positive signal. Price just got above it's 20-day simple moving average which is a positive signal. According to simple moving average analysis, auropharma is facing resistance from it's 20-day simple moving average at 994.6825 and support level is at 975. 6.0 AUROPHARMA Simple Moving Average Chart
Exponential Moving Average (?) Price just got above it's 50-day exponential moving average which is a positive signal. Price just got above it's 20-day exponential moving average which is a positive signal. According to exponential moving average analysis, auropharma is in a strong uptrend. Major support levels are 986.2576, 970.586, 887.6709. 9.0 AUROPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.496. 5.0 AUROPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 962.0588 and 930.6. Resistance level is 1063.9. 6.5 AUROPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 28.4 NA AUROPHARMA Average True Range Chart
Average Directional Index (?) ADX is 25.8 which means AUROPHARMA is in a trend. NA AUROPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
June 14, 2021
Open Price 1014.6
High Price 1018.0
Low Price 982.3
Close Price 994.3
Absolute Change -15.5
Percentage Change -1.53%
Weekly Change 3.63%
Monthly Change -0.803%
Yearly Change 26.5%
52-week high 1063.9
52-week low 738.05
Corporate Actions
ExDate Purpose
February 22, 2021 INT DIV - RS 1.50 PER SH
November 23, 2020 INTDIV - RS 1.25 PER SH
August 21, 2020 AGM/INTDIV-RS1.25 PER SH
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)1.05
Confidence in Beta3.07%
Market Capital Rs. 58068.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 14 June 2021: Deliverable Quantity:1.28e+06 NA AUROPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 14 June 2021: Daily Volatility:0.5197 NA AUROPHARMA Annualized Daily Volatility (Spot Price) Chart

Announcements

May 31, 2021 Financial Results Updates The Board of Directors of the Company at its meeting held today, May 31, 2021, has inter alia, considered and approved the standalone and consolidated Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We enclose herewith the said Audited Financial Results of the Company along with the Auditors Report issued by the Statutory Auditors. Pursuant to Regulation 33(3)(d) of SEBI Listing Regulations, we hereby confirm and declare that the Statutory Auditors of the Company, M/s. B S R & Associates LLP, Chartered Accountants, have issued the audit report on Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2021 with unmodified opinion.
February 11, 2021 Record Date Aurobindo Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 23-Feb-2021.
See all Announcements

Board Meetings

Date Meeting Date Purpose
May 25, 2021 May 31, 2021 Financial Results To consider and approve the financial results for the period ended March 31, 2021
February 01, 2021 February 10, 2021 Financial Results/Dividend To consider and approve the financial results for the period ended December 31, 2020 and dividend
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play